The maximum semaglutide dose of 2.0mg per week falls below the FDA-approved 2.4mg maximum for weight management
This significant difference underscores Retatrutide's potential upon approval
The safety of combining phentermine with semaglutide or tirzepatide depends on individual cardiovascular risk factors and should be evaluated by your healthcare provider
La vida media prolongada del medicamento permite una dosificacin conveniente una vez por semana en las formulaciones inyectables
avg body weight lost with Semaglutide (NEJM STEP 1 trial, 68 weeks) 2025% avg body weight lost with Tirzepatide (SURMOUNT-1, 7288 weeks) of semaglutide patients lost 5% of body weight (STEP 1 trial)of semaglutide patients lost 5% of body weight (STEP 1 trial) Week 14: Appetite reduction, smaller portions naturally Month 13: Steady fat loss begins, 12 lbs/week avg Month 36: Visible body composition change, reduced visceral fat 68 weeks: Average 14.9% total body weight reduction Ozempic for weight loss and Wegovy for weight loss produce comparable outcomes at equivalent doses
While not medically dangerous , the aesthetic and psychological impact can be significant